Back to Agenda
Session 2 Track 2 - Outlining the Pathway to a Paperless Trial
Session Chair(s)
Betsy Fallen, RN
Consultant
BAFallen Consulting LLC, United States
Learning Objective : After attending and participating in the QA, participants will be able to recognize the importance of adopting and evolving toward a paperless study start up. Participants should also be able to identify ways they can improve their start up (or clinical trail eTMF process) via a paperless system.
Speaker(s)
Technology Review: How to Implement Paperless Clinical Trial Technology into Your Clinical Trial: Feasibility to Close Out
Shannon Cooke, MS
TransPerfect Translations, United States
Project Manager
Update on eSource from a Regulators Perspective
Ron Fitzmartin, PhD, MBA
FDA, United States
Senior Informatics Advisor, Office of Regulatory Operations, CBER
Case Study: Practical Example of Running a Paperless Clinical Trial: Study Start up and eTMF Management
James Desanti
PharmaVigilant, United States
President and CEO
Have an account?